1 Answers
The recommended dosage for adult and pediatric patients 6 years of age and older is two inhalations four times a day at regular intervals, which provides a dose of 14 mg per day. In patients whose asthma is well controlled on this dosage (e.g., patients who only need occasional inhaled or oral beta2-agonists and who are not experiencing serious exacerbations), less frequent administration may be effective.
Each Nedocromil Inhaler canister must be primed with 3 actuations prior to the first use. If a canister remains unused for more than 7 days, then it should be reprimed with 3 actuations. Nedocromil Inhaler may be added to the patient's existing treatment regimen (e.g., bronchodilators). When a clinical response to Nedocromil Inhaler is evident and if the patient's asthma is under good control, an attempt may be made to decrease concomitant medication usage gradually. Proper inhalational technique is essential (see Patient Instructions for Use). Patients should be advised that the optimal effect of Nedocromil therapy depends upon its administration at regular intervals, even during symptom-free periods.
Pediatric Use: The safety and effectiveness of Nedocromil inhalation aerosol in patients below the age of 6 years have not been established.
Geriatric Use: Clinical studies of Nedocromil inhalation aerosol did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.
টিলেড ইনহেলার সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে টিলেড